Advanced search
Publication Cover
Acta Oncologica Volume 56, 2017 - Issue 11: 15th Acta Oncologica symposium: BiGART2017 - Biology-Guided Adaptive Radiotherapy - Aarhus, Denmark - June 13-16, 2017
Journal homepage
1,651
Views
16
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR

Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction

Patrick BerkovicDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgium; ;Department of Radiation Oncology, Liège University Hospital, Liège, Belgium; Correspondence[email protected]
,
Leen PaelinckDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgium;
,
Akos GulybanDepartment of Radiation Oncology, Liège University Hospital, Liège, Belgium;
,
Marc van EijkerenDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgium;
,
Veerle SurmontDepartment of Respiratory Medicine/Thoracic Oncology, Ghent University Hospital, Ghent, Belgium
,
Yolande LievensDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgium;
&
Katrien VandecasteeleDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgium;
show all
Pages 1656-1659 | Received 01 May 2017, Accepted 21 Jun 2017, Published online: 23 Aug 2017

Figures & data

Figure 1. Kaplan-Meier survival curves (with 95% CI and p-values from the log-rank test) on outcome based on the GTV-T shrinkage gradient.

Figure 1. Kaplan-Meier survival curves (with 95% CI and p-values from the log-rank test) on outcome based on the GTV-T shrinkage gradient.

Table 1. Dose volume histogram parameters from the initial and adaptive, and the fraction-based combination (sum adaptive).

Supplemental material

IONC_A_1352103_Supplementary_Information.zip

Download Zip (1.8 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials
Source: Elsevier BV
First clinical results of adaptive radiotherapy based on 3D portal dosimetry for lung cancer patients with atelectasis treated with volumetric-modulated arc therapy (VMAT)
Source: Informa UK Limited
Time Trends in Nodal Volumes and Motion During Radiotherapy for Patients With Stage III Non-Small-Cell Lung Cancer
Source: Elsevier BV
The European Society of Therapeutic Radiology and Oncology–European Institute of Radiotherapy (ESTRO–EIR) report on 3D CT-based in-room image guidance systems: A practical and technical review and guide
Source: Elsevier BV
Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients
Source: Informa UK Limited
Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction
Source: figshare Academic Research System
Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients
Source: Informa UK Limited
Potential of Adaptive Radiotherapy to Escalate the Radiation Dose in Combined Radiochemotherapy for Locally Advanced Non–Small Cell Lung Cancer
Source: Elsevier BV
Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer
Source: Elsevier BV
Motion Analysis of 100 Mediastinal Lymph Nodes: Potential Pitfalls in Treatment Planning and Adaptive Strategies
Source: Elsevier BV
Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy
Source: Elsevier BV
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
Source: Informa UK Limited
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Source: Elsevier BV
Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients
Source: Elsevier BV
Adaptive Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Does Not Underdose the Microscopic Disease and has the Potential to Increase Tumor Control
Source: Elsevier BV
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
Source: Oxford University Press (OUP)
Cone-beam computed tomography for lung cancer - validation with CT and monitoring tumour response during chemo-radiation therapy
Source: Wiley-Blackwell
Interfractional changes in tumour volume and position during entire radiotherapy courses for lung cancer with respiratory gating and image guidance
Source: Informa UK Limited
BIGART 2019 – adapting to the future
Source: Informa UK Limited
Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction
Source: Taylor & Francis
Conformal radiotherapy of stage III non–small cell lung cancer: a class solution involving non–coplanar intensity-modulated beams
Source: Elsevier BV
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Source: American Society of Clinical Oncology (ASCO)
Quantitative Computed Tomographic Indexes in Diffuse Interstitial Lung Disease
Source: Ovid Technologies (Wolters Kluwer Health)
Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction
Source: Taylor & Francis
Tumor, Lymph Node, and Lymph Node-to-Tumor Displacements Over a Radiotherapy Series: Analysis of Interfraction and Intrafraction Variations Using Active Breathing Control (ABC) in Lung Cancer
Source: Elsevier BV
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
Source: American Society of Clinical Oncology (ASCO)
A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning
Source: IOP Publishing
Adaptive Radiotherapy for Lung Cancer
Source: Elsevier BV
Globocan 2012
Source: Wiley
Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.